![Fabienne Steens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabienne Steens
Chief Investment Officer bij Biomedical Diagnostics NV
Actieve functies van Fabienne Steens
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Biomedical Diagnostics NV
![]() Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Directeur/Bestuurslid | 28-01-2003 | - |
Chief Investment Officer | 28-01-2003 | - |
Loopbaan van Fabienne Steens
Statistieken
Internationaal
België | 2 |
Operationeel
Director/Board Member | 1 |
Chief Investment Officer | 1 |
Sectoraal
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Biomedical Diagnostics NV
![]() Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Distribution Services |
- Beurs
- Insiders
- Fabienne Steens
- Ervaring